Advertisement

Opioids pp 107-123 | Cite as

Opioid Receptor Regulation

  • R. S. Zukin
  • D. E. Pellegrini-Giampietro
  • C. M. Knapp
  • A. Tempel
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 104 / 1)

Abstract

The actions of opiates and opioid peptides upon nervous tissue are mediated by μ-, δ, and κ-opioid receptors and (in the case of σ-opioids) the PCP site of the NMD A receptor (for a review see Chap. 1). The three opioid receptors exhibit different ligand selectivities, strikingly different neuroanatomical patterns, distinct physiological and behavioral profiles, and differing sensitivities to naloxone (or naltrexone) antagonism. In the central nervous system (CNS) these receptors are activated by three classes of structurally related peptides, β-endorphin, the enkephalins, and the dynorphin-related peptides, encoded by three different genes. The observation that opiate analgesics produce tolerance and dependence suggests that opioid systems can undergo plastic changes. This chapter focuses on studies of the regulation of μ- and δ-opioid receptors. A particular emphasis is placed upon examination of mechanisms by which chronic treatment of opioid drugs quantitatively regulates opioid receptors in adult, embryonic, and neonatal brain.

Keywords

Opioid Receptor Opioid Peptide Opiate Receptor Chronic Morphine Electroconvulsive Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bardo MT, Bhatnagar RK, Gebhardt GF (1982) Differential effects of chronic morphine and naloxone on opiate receptors, monoamines, and morphine- induced behaviors in preweanling rats. Dev Brain Res 4: 139–147CrossRefGoogle Scholar
  2. Bardo MT, Bhatnagar RK, Gebhardt GF (1983) Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat. Brain Res 289: 223–234PubMedCrossRefGoogle Scholar
  3. Barg J, Simantov R (1990) Depolarization regulates selectively the expression of different opioid receptors: a decreased number of kappa receptors in chronically activated guinea pig brain cell cultures. Neurosci Lett 111: 222–227PubMedCrossRefGoogle Scholar
  4. Barr GA, Paredes W, Erickson KL, Zukin RS (1986) Kappa opioid receptor- mediated analgesia in the developing rat. Dev Brain Res 29: 145–152CrossRefGoogle Scholar
  5. Bauman PS, Levine SA (1986) The development of children of drug addicts. Int J Addict 21: 849–863PubMedGoogle Scholar
  6. Bergstrom L, Terenius L (1983) Enkephalin levels decrease in rat striatum during morphine abstinence. Eur J Pharmacol 60: 349–352CrossRefGoogle Scholar
  7. Bhargava HN, Ramarao P, Gulati A (1989a) Effects of morphine in rats treated chronically with U-50, 488H, a kappa opioid receptor agonist. Eur J Pharmacol 162: 257–264PubMedCrossRefGoogle Scholar
  8. Bhargava HN, Gulati A, Ramarao P (1989b) Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J Pharmacol Exp Ther 251: 21–26PubMedGoogle Scholar
  9. Blanchard SG, Chang KJ, Cuatrecasas P (1982) Studies on the mechanism of enkephalin receptor down regulation. Life Sci 31: 1311–1314PubMedCrossRefGoogle Scholar
  10. Blume AJ (1978) Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proc Natl Acad Sci USA 75: 1713–1717PubMedCrossRefGoogle Scholar
  11. Brady LS, Herkenham M, Long JB, Rothman RB (1989) Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 477: 382–386PubMedCrossRefGoogle Scholar
  12. Brunello N, Volterra A, DiGiulio AM, Cuomo V, Racagni G (1984) Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates. Life Sci 34: 1669PubMedCrossRefGoogle Scholar
  13. Chang KJ, Cuatrecasas P (1979) Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity. J Biol Chem 254: 2610–2618PubMedGoogle Scholar
  14. Chang KJ, Miller RJ, Cuatrecasas P (1978) Interaction of enkephalin with opiate receptors in intact cultured cells. Mol Pharmacol 14: 961–970PubMedGoogle Scholar
  15. Chang KJ, Hazum E, Killian A, Cuatrecasas P (1981) Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. Mol Pharmacol 20: 1–7PubMedGoogle Scholar
  16. Chang KJ, Eckel RW, Blanchard SG (1982) Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature 296: 446–448PubMedCrossRefGoogle Scholar
  17. Cherubini E, North RA (1985) Mu and κ opioids inhibit transmitter release by different mechanisms. Proc Natl Acad Sci USA 82: 1860PubMedCrossRefGoogle Scholar
  18. Childers SR, Simantov R, Snyder SH (1977) Enkephalin: radioimmunoassay and radioreceptor assay in morphine dependent rats. Eur J Pharmacol 46: 289–293PubMedCrossRefGoogle Scholar
  19. Clendeninn NJ, Petraitis M, Simon EJ (1976) Ontological development of opiate receptors in rodent brain. Brain Res 118: 157–160PubMedCrossRefGoogle Scholar
  20. Coyle JT, Pert CB (1976) Ontogenetic development of [3H] naloxone binding in rat brain. Neuropharmacology 15: 555–560PubMedCrossRefGoogle Scholar
  21. Crain SM, Shen KF (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 11: 77–81PubMedCrossRefGoogle Scholar
  22. Danks JA, Tortella FC, Long JB, Bykov V, Jacobson KC, Rice JW, Holaday, Rothman RB (1988) Chronic administration of morphine and naltrexone up- regulate [3H] (D-Ala2, D-Leu5) enkephalin binding sites by different mechanisms. Neuropharmacology 27: 965–974PubMedCrossRefGoogle Scholar
  23. Davis ME, Akera T, Brody TM (1979) Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats. J Pharmacol Exp Ther 211: 112–119PubMedGoogle Scholar
  24. Deren S (1986) Children of substance abusers: a review of the literature. J Subst Abuse Treat 3: 77–94PubMedCrossRefGoogle Scholar
  25. Elsworth JD, Redmond DE Jr, Roth RH (1986) Effect of morphine treatment and withdrawal on endogenous methionine- and leucine-enkephalin levels in primate brain. Biochem Pharmacol 35: 3415–3417PubMedCrossRefGoogle Scholar
  26. Fratta W, Yang H-YT, Hong J, Costa E (1977) Stability of met-enkephalin content in brain structures of morphine-dependent or foot-shock stressed rats. Nature 268: 452–453PubMedCrossRefGoogle Scholar
  27. Frost JJ, Mayberg HS, Fisher RS, Douglass KH, Dannals RF, Links JM, Wilson AA, Ravert HT, Rosenbaum AE, Snyder SH (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 23: 231–237PubMedCrossRefGoogle Scholar
  28. Gardner EL, Zukin RS, Makman MH (1980) Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res 194: 232–239PubMedCrossRefGoogle Scholar
  29. Genazzani AR, Petraglia F, Giudetti R, Volpe A, Facchinetti F (1986) Neonatal β-endorphin secretion in babies passively addicted to opiates. Excerpta Med Int Congr Ser 369: 379–382Google Scholar
  30. Guitart X, Nestler EJ (1989) Identification of morphine and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain. Regulation by acute and chronic morphine. J Neurosci 9: 4371–4387Google Scholar
  31. Guitart X, Hayward MD, Nisenbaum LK, Beitner-Johnson DB, Haycock JW, Nestler EJ (1990) Identification of MARPP-58, a morphine- and cyclic AMP- regulated phosphoprotein of 58kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J Neurosci 10: 2649–2659PubMedGoogle Scholar
  32. Handelmann GE, Quirion R (1983) Neonatal exposure to morphine increases mu opiate binding in the adult forebrain. Eur J Pharmacol 94: 357–358PubMedCrossRefGoogle Scholar
  33. Hayward MD, Duman RS, Nestler EJ (1990) Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res 525: 256–266PubMedCrossRefGoogle Scholar
  34. Hazum E, Chang KJ, Cuatrecasas P (1979) Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cells. Nature 282: 626–628PubMedCrossRefGoogle Scholar
  35. Herkenham M, Pert CB (1981) Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291: 415–418PubMedCrossRefGoogle Scholar
  36. Hitzemann RJ, Hitzemann BA, Loh HH (1974) Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development. Life Sci 14: 2393–2404PubMedCrossRefGoogle Scholar
  37. Hitzemann RJ, Hitzemann BA, Blatt S, Meyerhoff JL, Tortella FC, Kenner JR, Belenky GL, Holaday JW (1987) Repeated electroconvulsive shock: effect on sodium dependency and regional distribution of opioid-binding sites. Mol Pharmacol 31: 562–566PubMedGoogle Scholar
  38. Holaday JW, Hitzemann RJ, Curell J, Tortella FC, Belenky GL (1982) Repeated electroconvulsive shock or chronic morphine treatment increases the number of 3H-D-Ala2-D-Leu5-enkephalin binding sites in rat brain membranes. Life Sci 31: 2359–2362PubMedCrossRefGoogle Scholar
  39. Holaday JW, Tortella FC, Meyerhoff JL, Belenky GL, Hitzemann RJ (1986) Electroconvulsive shock activates endogenous opioids systems: behavioral and biochemical correlates. Ann NY Acad Sci 467: 249–255PubMedCrossRefGoogle Scholar
  40. Höllt V, Dum J, Blasig J, Schubert P, Herz A (1975) Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant/dependent rodents. Life Sci 16: 1823–1828PubMedCrossRefGoogle Scholar
  41. Höllt V, Przewlocki R, Herz A (1978) P-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. Life Sci 23: 1057–1066PubMedCrossRefGoogle Scholar
  42. Iyengar S, Rabii J (1982) Effect of prenatal exposure to morphine on the postnatal development of opiate receptors. Fed Proc 41: 1354–1357Google Scholar
  43. Kent JL, Pert CB, Herkenham M (1982) Ontogeny of opiate receptors in rat forebrain: visualization by in vitro autoradiography. Dev Brain Res 2: 487–504CrossRefGoogle Scholar
  44. Kirby ML, Aronstam RS (1983) Levorphanol-sensitive [3H] naloxone binding in developing brainstem following prenatal morphine exposure. Neurosci Lett 35: 191–195PubMedCrossRefGoogle Scholar
  45. Kirby ML, Gale TF, Mattio TG (1982) Effects of prenatal capsaicin treatment on fetal spontaneous activity, opiate receptor binding, and acid phosphatase in the spinal cord. Exp Neurol 76: 298–308PubMedCrossRefGoogle Scholar
  46. Klee WA, Nirenberg M (1976) Mode of action of endogenous opiate peptides. Nature 248: 609–612CrossRefGoogle Scholar
  47. Klee WA, Lampert A, Nirenberg M (1976) Dual regulation of adenylate cyclase by endogenous opiate peptides. In: Kosterlitz HW (ed) Opiates and endogenous opioid peptides. Elsevier/North-Holland, New York, pp 153–159Google Scholar
  48. Lahti RA, Collins RJ (1978) Chronic naloxone results in prolonged increases in opiate binding sites in brain. Eur J Pharmacol 51: 185–186PubMedCrossRefGoogle Scholar
  49. Lampert A, Nirenberg M, Klee WA (1976) Tolerance and dependence evoked by an endogenous opiate peptide. Proc Natl Acad Sci USA 73: 3165–3167PubMedCrossRefGoogle Scholar
  50. Law PY, Horn DS, Loh HH (1983) Opiate receptor downregulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol 24: 413–424PubMedGoogle Scholar
  51. Lenoir D, Barg J, Simantov R (1983) Down-regulation of opiate receptors in serum- free cultures of aggregating fetal brain cells. Life Sci 33 [Suppl 1]: 337–340PubMedCrossRefGoogle Scholar
  52. Leslie FM, Tso S, Hurlbut DE (1982) Differential appearance of opiate receptor subtypes in neonatal rat brain. Life Sci 31: 1393–1396PubMedCrossRefGoogle Scholar
  53. Lesser-Katz M (1982) Some effects of maternal drug addiction on the neonate. Int J Addict 17: 887–896PubMedGoogle Scholar
  54. Loughlin SE, Massamiri T, Kornblum HI, Leslie FM (1985) Postnatal development of opioid systems in rat brain. Neuropeptides 5: 469–472PubMedCrossRefGoogle Scholar
  55. McDonald RL, Werz MA (1986) Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones. J Physiol (Lond) 377: 237–249Google Scholar
  56. Miyake M, Christie MJ, North RA (1989) Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc Natl Acad Sci USA 86: 3419–3422PubMedCrossRefGoogle Scholar
  57. Moon SL (1984) Prenatal haloperidol alters striatal dopamine and opiate receptors. Brain Res 323: 109–113PubMedCrossRefGoogle Scholar
  58. Morris BJ, Herz A (1989) Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonists/antagonist treatment. Neuroscience 29: 433–442PubMedCrossRefGoogle Scholar
  59. Nakata Y, Chang KJ, Mitchell CL, Hong JS (1985) Repeated electroconvulsive shock down regulates the opioid receptors in rat brain. Brain Res 346: 160–163PubMedCrossRefGoogle Scholar
  60. Nestler EJ, Tallman JF (1988) Chronic morphine treatment increases cyclic AMP- dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol 33: 127–132PubMedGoogle Scholar
  61. Nishino K, Su YF, Wong CS, Watkins WD, Chang KJ (1990) Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J Pharmacol Exp Ther 253: 67–72PubMedGoogle Scholar
  62. North RA (1986) Opioid receptor types and membrane ion channels. Trends Neurosci 9: 114–117CrossRefGoogle Scholar
  63. North RA, Williams JT (1983) Opiate activation of potassium conductance inhibits calcium action potentials in rat locus coeruleus neurones. Br J Pharmacol 80: 225PubMedGoogle Scholar
  64. Panerai AE, Martini A, di Giulio AM, Fraioli F, Vegni C, Pardi G, Marini A, Mantegazza P (1983) Plasma β-endorphin, β-lipotropin, and met-enkephalin concentrations during pregnancy in normal and drug-addicted women and their newborn. J Clin Endocrinol Metab 57: 537–543PubMedCrossRefGoogle Scholar
  65. Pert CB, Pasternak GW, Snyder SH (1973) Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182: 1359–1361PubMedCrossRefGoogle Scholar
  66. Petrillo P, Tavani A, Verotta D, Robson LE, Kosterlitz HW (1987) Differential postnatal development of mu-, delta-, and kappa-opioid binding sites in rat brain. Brain Res 428: 53–58PubMedGoogle Scholar
  67. Przewlocki R, Höllt V, Duka T, Kleber G, Gramsch C, Haarmann I, Herz A (1979) Long-term morphine treatment decreases endorphin levels in rat brain and pituitary. Brain Res 174: 357–361PubMedCrossRefGoogle Scholar
  68. Puttfarken PS, Cox BM (1989) Morphine-induced desensitization and down- regulation at mu-receptors in 7315C pituitary tumor cells. Life Sci 45: 1937–1942CrossRefGoogle Scholar
  69. Ragavan VV, Wardlaw SL, Kreek MJ, Frantz AG (1983) Effect of chronic naltrexone and methadone administration on brain immunoreactive beta- endorphin in the rat. Neuroendocrinology 37: 266–268PubMedCrossRefGoogle Scholar
  70. Rothman RB, Danks JA, Jacobson AE, Burke TR, Rice KC, Tortella F, Holaday JW (1986) Morphine tolerance increases mu-noncompetitive delta binding sites. Eur J Pharmacol 124: 113–119PubMedCrossRefGoogle Scholar
  71. Schulz R, Wüster M, Herz A (1979) Supersensitivity to opioids following chronic blockade of endorphin activity by naloxone. Naunyn Schmiedebergs Arch Pharmacol 306: 93–96PubMedCrossRefGoogle Scholar
  72. Shani J, Azov R, Weissman BA (1979) Enkephalin levels in rat brain after various regimens of morphine administration. Neurosci Lett 12: 319–322PubMedCrossRefGoogle Scholar
  73. Sharma SK, Klee WA, Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72: 3092–3096PubMedCrossRefGoogle Scholar
  74. Shen KF, Crain SM (1989) Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res 491: 227–242PubMedCrossRefGoogle Scholar
  75. Simantov R, Amir S (1983) Regulation of opiate receptors in mouse brain: arcuate nuclear lesion induces eceptor up-regulation and supersensitivity to opiates. Brain Res 262: 168–171PubMedCrossRefGoogle Scholar
  76. Simantov R, Levy R (1989) Neuronal activation regulates the expression of opioid receptors: possible role of glial-derived factors and voltage-dependent ion channels. J Neurochem 52: 305–309PubMedCrossRefGoogle Scholar
  77. Simantov R, Levy R, Baram D (1982) Down regulation of enkephalin (5) receptors: demonstration in membrane bound and solubilized receptors. Biochem Biophys Acta 721: 478–484PubMedCrossRefGoogle Scholar
  78. Spain JW, Roth BL, Coscia CJ (1985) Differential ontogeny of multiple opioid receptors (μ, δ, and κ). J Neurosci 5: 584–588PubMedGoogle Scholar
  79. Steece KA, DeLeon-Jones FA, Myerson LR, Lee JM, Fields JZ, Ritzman RF (1986) In vivo down-regulation of rat striatal opioid receptors by chronic enkephalin. Res Bull 17: 255–257CrossRefGoogle Scholar
  80. Tang AH, Collins RJ (1978) Enhanced analgesic effects of morphine after chronic administration of naloxone in the rat. Eur J Pharmacol 47: 473–474PubMedCrossRefGoogle Scholar
  81. Tao PL, Law PY, Loh HH (1987) Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240: 809–816PubMedGoogle Scholar
  82. Tao PL, Li R, Chang KL, Law PY, Loh HH (1988) Decrease in delta-receptor density in rat brain after chronic (D-Ala2, D-Leu5) enkephalin treatment. Brain Res 462: 313–320PubMedCrossRefGoogle Scholar
  83. Tavani A, Robson L, Kosterlitz HW (1985) Differential postnatal development of mu, delta, and kappa opioid binding sites in mouse brain. Dev Brain Res 23: 306–309CrossRefGoogle Scholar
  84. Tempel A, Gardner EL, Zukin RS (1984) Visualization of opiate receptor up- regulation by light microscopy autoradiography. Proc Natl Acad Sci USA 81: 3893–3897PubMedCrossRefGoogle Scholar
  85. Tempel A, Gardner EL, Zukin RS (1985) Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther 232: 439–444PubMedGoogle Scholar
  86. Tempel A, Habas JE, Paredes W, Barr GA (1988) Morphine-induced down- regulation of μ-opioid receptors in neonatal rat brain. Dev Brain Res 41: 129–133CrossRefGoogle Scholar
  87. Tempel A, Kessler JA, Zukin RS (1990) Chronic naltrexone treatment increases expression of preproenekphalin and preprotachykinin mRNA in discrete brain regions. J Neurosci 10: 741–747PubMedGoogle Scholar
  88. Torda C (1978) Effects of recurrent postnatal pain-related stressful events on opiate receptor-endogenous ligand system. Psychoneuroendrocrinology 3: 85–91CrossRefGoogle Scholar
  89. Tsang D, Ng SC (1980) Effect of antenatal exposure to opiates on the development of opiate receptors in rat brain. Brain Res 188: 199–206PubMedCrossRefGoogle Scholar
  90. Tsang D, Ng SC, Ho KP (1982) Kappa opioid receptor-mediated analgesia in the developing rat. Brain Res 394: 145–152Google Scholar
  91. Uhl G, Ryan JP, Schwartz JP (1988) Morphine alters preproenkephalin gene expression. Brain Res 459: 391–397PubMedCrossRefGoogle Scholar
  92. Watanabe Y, Shibuya T, Salafsky B, Hill HF (1983) Prenatal and postnatal exposure to diazepam: effects on opioid receptor binding in rat brain cortex. Eur J Pharmacol 96: 141–144PubMedCrossRefGoogle Scholar
  93. Werling LL, McMahon PN, Cox BM (1989) Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86: 6393–6397PubMedCrossRefGoogle Scholar
  94. Werz MA, McDonald RL (1985) Dynorphin and neoendorphin peptides decrease dorsal root ganglion enuron calcium-dependent action potential duration. J Pharmacol Exp Ther 234: 49PubMedGoogle Scholar
  95. Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE (1985) Increased analgesic potency of morphine and increased brain opioid bindings sites in the rat following chronic naltrexone treatment. Life Sci 36: 2325–2332PubMedCrossRefGoogle Scholar
  96. Yoburn BC, Sierra V, Lutfy K (1989) Chronic opioid antagonist treatment: assessment of receptor upregulation. Eur J Pharmacol 170: 193–200PubMedCrossRefGoogle Scholar
  97. Young E, Olney J, Akil A (1982) Increase in delta, but not mu, receptors in MSG-treated rats. Life Sci 31: 1343–1346PubMedCrossRefGoogle Scholar
  98. Young WS, Kuhar MJ (1979) A new method for receptor autoradiography: [3H]opioid receptors in rat brain. Brain Res 179: 225–270Google Scholar
  99. Zukin RS, Sugarman JR, Fitz-Syage ML, Gardner EL, Zukin SR, Gintzler AR (1982) Naltrexone-induced opiate receptor supersensitivity. Brain Res 245: 285–292PubMedCrossRefGoogle Scholar
  100. Zukin RS, Eghbali M, Olive D, Unterwald E, Tempel A (1988) Characterization and visualization of rat and guinea-pig kappa opioid receptors: evidence for kappa1 and kappa2 receptors. Proc Natl Acad Sci USA 85: 4061–4065PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • R. S. Zukin
  • D. E. Pellegrini-Giampietro
  • C. M. Knapp
  • A. Tempel

There are no affiliations available

Personalised recommendations